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Abstract
Background: Alteration in menstrual cycle function is suggested among rhesus monkeys and humans exposed to
polybrominated biphenyls (PBBs) and structurally similar polychlorinated biphenyls (PCBs). The feedback system for
menstrual cycle function potentially allows multiple pathways for disruption directly through the hypothalamic-pituitary-
ovarian axis and indirectly through alternative neuroendocrine axes.
Methods: The Michigan Female Health Study was conducted during 1997–1998 among women in a cohort exposed to
PBBs in 1973. This study included 337 women with self-reported menstrual cycles of 20–35 days (age range: 24–56 years).
Current PBB levels were estimated by exponential decay modeling of serum PBB levels collected from 1976–1987 during
enrollment in the Michigan PBB cohort. Linear regression models for menstrual cycle length and the logarithm of bleed
length used estimated current PBB exposure or enrollment PBB exposure categorized in tertiles, and for the upper
decile. All models were adjusted for serum PCB levels, age, body mass index, history of at least 10% weight loss in the
past year, physical activity, smoking, education, and household income.
Results: Higher levels of physical activity were associated with shorter bleed length, and increasing age was associated
with shorter cycle length. Although no overall association was found between PBB exposure and menstrual cycle
characteristics, a significant interaction between PBB exposures with past year weight loss was found. Longer bleed length
and shorter cycle length were associated with higher PBB exposure among women with past year weight loss.
Conclusion: This study suggests that PBB exposure may impact ovarian function as indicated by menstrual cycle length
and bleed length. However, these associations were found among the small number of women with recent weight loss
suggesting either a chance finding or that mobilization of PBBs from lipid stores may be important. These results should
be replicated with larger numbers of women exposed to similar lipophilic compounds.
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In 1973, the fire retardant chemical, FireMaster®, was mis-
taken for NutriMaster®, a magnesium oxide-based cattle
feed supplement, and was inadvertently introduced into
cattle feed (Michigan Chemical Corporation, St. Louis,
MI). Thousands of farm families and farm product con-
sumers were exposed to this commercial mixture of poly-
brominated biphenyl (PBB) congeners throughout
Michigan. Concern about possible adverse health effects
led to the establishment of the Michigan PBB Long-Term
Study in 1976 by the Michigan Department of Commu-
nity Health (MDCH). The incident is described in detail
elsewhere [1,2].
From 1997–1998, the Michigan Female Health Study
(MFHS) was conducted to assess whether PBB exposure
disrupted endocrine function among cohort women.
Only one rhesus monkey study was found, suggesting that
PBBs may be associated with longer menstrual cycles [3].
Animal studies of structurally similar polychlorinated
biphenyls (PCBs) have found that menstrual cycle length
was either not different [4-7] or longer [8] with Aroclor
1248 [4,8] or Aroclor 1254 [5-7] dosing. Bleed length was
marginally longer in the higher Aroclor 1254 dose groups
[5-7]. Human PCB studies are also inconsistent. Shorter
cycle length was associated with indices of PCB-contami-
nated fish consumption [9]. When summed over meas-
ures of selected PCB congeners, cycle length was longer
with higher total PCB levels in a large multicenter cohort
[10], but not among Southeast Asian immigrants [11].
Cooper et al reported that bleed length was not associated
with PCBs [10], but Yucheng women, with cooking oil
exposure to PCBs, reported abnormal bleeding more
often than controls [12].
Endocrine regulation is a complex process and may be dis-
rupted at many points. The immune and neuroendocrine
systems are integrated in a network of the ovarian, thy-
roid, thymus, and adrenal axes. This network is regulated
or disrupted through feedforward and feedback loops of
the hypothalamus, the pituitary, and associated end-
organs of the neuroendocrine axes [13-15].
Cycle length and bleed length, although nonspecific, are
markers for the reproductive status of women undergoing
cyclical ovulation and endometrial angiogenesis under
hormonal feedback and control [16-20]. This study
assessed whether serum PBB levels were associated with
these markers of menstrual cycle function among women
still menstruating in the year before interview.
Methods
The Michigan Female Health Study design and data 
collection
The release of PBBs into the Michigan food chain was lim-
ited in geographic distribution and in duration due to the
environmental remediation of quarantined farms and the
food chain. Michigan PBB cohort enrollment data, along
with blood samples for exposure biomonitoring that
included PBB and PCB, were collected from 1976–1987
by the MDCH.
The study design of the MFHS is a follow-up prevalence
study [21]. It is a hybrid study of an exposure cohort fol-
lowed prospectively to assess the prevalence of current
menstrual cycle outcomes. Data were collected for the
MFHS during August 1997 through April 1998 by compu-
ter-assisted telephone interview. Participants were asked
about reproductive history, menstrual cycle characteris-
tics, physical activity, smoking habits, medication, physi-
cian-diagnosed medical conditions, and other health and
demographic information. The MFHS was approved by
the institutional review boards of Emory University,
MDCH, and the Centers for Disease Control and
Prevention.
Eligibility for menstrual cycle analyses
A total of 1020 women in the MFHS had serum levels of
PBB available from cohort enrollment. This study was
restricted to women who were born before the exposure
incident, which is estimated to have occurred as early as
July 1, 1973 [22]. In this manner, we restricted the analy-
ses to women solely exposed by food ingestion and not in
utero.
Women were asked to report their usual non-pregnancy
related cycle length during the past year, defined as the
number of days from the first day of menstrual bleed to
the first day of the next menstrual bleed. The distribution
of menstrual cycle length across the reproductive lifespan
represents a mixture between normal ovulatory cycles and
short or long anovulatory bleeding episodes at both age
extremes [23-25]. Long cycles in the right tail are influ-
enced by older women in perimenopausal status [24,25]
with more frequent ovulatory failure [23]. Among women
aged 25–44 years, Metcalf observed that 93.6% of all
cycles were between 20–35 days in length with a pattern
of consistently ovulatory cycles [23]. We lacked laboratory
confirmation and referred to the women in this study as
having normal, not ovulatory, cycles. We decomposed the
distribution of cycle length into an approximately sym-
metric part centered about 28 days (n = 338) and a long
right tail (n = 12). We restricted our analysis to women
with cycle lengths ranging from 20–35 days (n = 337),
excluding a subject with a 14-day cycle length (Figure 1).
Other studies define normal cycles from 21–35 days [26],Page 2 of 14
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ommend cycle lengths of 18–40 days [25].
We excluded women from menstrual cycle analyses if they
indicated any of the following during the past year: no
menstrual cycles, menstrual cycles shorter than 20 days or
longer than 35 days, breastfeeding, or use of hormone
medications. We also excluded ten women with missing
data (Figure 1).
We restricted bleed length analyses to the same women
who were eligible for cycle length analyses. Women
reported their usual length of menstrual bleeding in the
past year as a single estimate or a range in days. Bleed
length for women reporting a range was taken as the mid-
point between the two values.
Measurement of enrollment serum PBB and PCB 
concentrations
PCBs and PBBs have 209 theoretically possible congeners.
By weight, FireMaster® was 54%–68% PBB 153, a non-
coplanar congener. Several coplanar congeners were
present in the mixture in smaller amounts [22,27]. Serum
concentrations of PBB 153, in parts per billion (ppb),
were quantified by gas chromatography with electron cap-
ture detection using established protocols. The limit of
detection (LOD) was 1 ppb. These PBB 153 measures are
indicators of total PBB exposure [28,29].
Up to 1982, total PCBs were quantified as Aroclor 1254
(Montsano Company, St. Louis, MO) levels with the LOD
at 5 ppb. Between 1982–1993, Aroclor 1260 (Montsano
Company, St. Louis, MO) levels were assessed with the
LOD at 3 ppb. We combined initial total PCB levels from
the two assay methods, assuming any total below 5 ppb
was below the LOD. Only three women (0.9%) had initial
Aroclor 1260 levels, all below 3 ppb. Changing PCB ana-
lytical methods did not result in misclassification of expo-
sure rank in this sample.
Estimation of current serum PBB concentration
We hypothesized that current PBB levels were associated
with current menstrual function. We used serum PBB
enrollment measurements to estimate individual current
PBB levels, using an exponential decay model described
previously [30]. The original decay model included
women who were at least 16 years old at enrollment with
initial PBB levels of 2 ppb or higher. They also had at least
two nonpregnancy serum samples drawn. The authors
found that overall, median half-life was 13.5 years, but
decay was slower among women with high enrollment
BMI. Parity, age at enrollment, smoking history, and
breastfeeding duration were not significant predictors of
decay [30]. The estimated levels from the decay model
were highly correlated with measured levels (r = 0.92)
[31].
We used the same equation specified in the decay model
for our estimates. We assigned enrollment PBB levels less
than or equal to 1 ppb a value of 0.5 ppb, a value half way
between zero and the LOD. This enabled log-transforma-
tions [32], and has been shown to be an appropriate
imputation technique [33]. We included data from the
MDCH archives: linear and quadratic terms for the loga-
rithm of enrollment PBB level, categories of body mass
index (BMI) at enrollment (less than/greater than or equal
to 23.0 kg/m2), and age at enrollment. We also included
data from the MFHS: number of full-term pregnancies
between enrollment and interview, breastfeeding dura-
tion (months), and smoking status (ever/never). Because
these data were modeled, we did not impose an LOD on
the estimated levels.
Eligibility for menstrual cycle analysis, Michigan Female Health Study, 1997–1998Fi ure 1
Eligibility for menstrual cycle analysis, Michigan Female Health 
Study, 1997–1998.Page 3 of 14
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PBB and PCB exposures were ranked in low, middle, and
high exposure categories. Tertiles were our primary classi-
fication for estimated current PBBs: with low, from zero to
0.06 ppb (n = 112) as referent; middle, from greater than
0.06–0.32 ppb (n = 113); and high, at greater than 0.32
ppb (n = 112). We also performed analyses with estimated
current PBBs categorized for highest exposure, retaining
the lowest tertile as the referent and classifying the upper
decile at greater than 3.08 ppb (n = 35).
Classification of PBB exposure at cohort enrollment
We categorized laboratory measures of PBB at enrollment
into approximate tertiles: at or below the LOD of 1 ppb (n
= 111) as referent; from greater than 1 to 3 ppb (n = 120);
and greater than 3 ppb (n = 106). We classified enroll-
ment PBB levels greater than 12 ppb (n = 37) as the upper
decile, retaining the same referent group.
Classification of PCB exposure
We used initial serum PCB measurements. We did not
attempt to model the decay and bioaccumulation of PCBs
due to changes in the laboratory assessment from Aroclor
1254 to Aroclor 1260. We also did not have information
on important factors of PCB bioaccumulation, such as
fish consumption. We divided PCB exposure into four cat-
egories. The lowest referent category included measure-
ments at or below the LOD or 5 ppb (n = 178); the middle
category, from greater than 5 to 7 ppb (n = 53); the high
category, at greater than 7 ppb (n = 62); and missing (n =
44).
Statistical analyses
We performed multiple linear regressions with cycle
length and with the natural logarithm of bleed length as
continuous outcomes. We examined the distributions of
the continuous variables to better meet the assumptions
of normality in linear regression models. We did not
apply data transformations for age and BMI at interview,
or for cycle length restricted to 20–35 days (median 28.0;
mean 27.7 days; standard deviation (SD) 2.9; skewness -
0.42; kurtosis 0.70) (Figure 2). Bleed length was right-
skewed (median 5.0; mean 5.3; SD 1.3; skewness 0.87;
kurtosis 2.5) (Figure 3). We log-transformed bleed length
to center the distribution (median 1.61; mean 1.63; SD
0.25; skewness -0.37; kurtosis 1.91). We verified that the
quantile-quantile (QQ) plot for log-transformed bleed
length linearized the curved point pattern we observed in
the QQ plot for bleed length. We performed collinearity
diagnostics, and centered age and BMI about their respec-
tive means (37.8 years and 26.6 kg/m2) to reduce inflated
variances in the models.
We retained the same covariates in all regression models
across both cycle length and bleed length analyses. Cate-
gorical covariates included PCBs, usual weekly physical
activity, smoking status, educational attainment, income
level, and loss of 10% of body weight or more in the past
year unrelated to pregnancy. We defined never exercising
as low, one or two times per week as moderate, and exer-
cising three or more times per week as high levels of recre-
ational physical activity.
Distribution of menstrual cycle length, Michigan Female Health Study, 1997–1998Figure 2
Distribution of menstrual cycle length, Michigan Female 
Health Study, 1997–1998
Distribution of bleed length, Michigan Female Health Study, 1997–1998Figure 3
Distribution of bleed length, Michigan Female Health Study, 
1997–1998Page 4 of 14
(page number not for citation purposes)
Environmental Health: A Global Access Science Source 2005, 4:15 http://www.ehjournal.net/content/4/1/15We evaluated interactions of PBB categories with age and
BMI at interview, weight loss, and physical activity for all
models. Interaction assessment for age or BMI with PBBs
included testing linear and quadratic terms. When signifi-
cant interactions between age and PBB categories were
detected, diagnostic tests were repeated with age quintiles.
The age range for the first quintile was 24–31 years (n =
59); the second, 32–35 years (n = 70); the third, 36–38
years (n = 64) as the referent group; the fourth, 39–43
years (n = 74); and the fifth, 44–56 years (n = 70). We also
evaluated possible additive or synergistic effects between
exposures to PBBs and PCBs or cigarette smoking by inter-
action assessment. We exponentiated point estimates and
confidence intervals for the difference in the logarithm of
bleed length and reported the converted differences in
bleed length as a ratio on the original scale, in days.
The decay model we used to estimate current PBB levels
was originally developed using different criteria than the
inclusion criteria for this study. We performed sensitivity
analyses by repeating our models excluding females less
than 16 years at enrollment (n = 140).
We performed secondary analyses for the full distribution
of menstrual cycle length, including women in the long
right tail. Logistic regression models would not converge
due to small cell sizes with long cycles classified as greater
than 35 days (n = 12; upper 3%). We redefined long cycles
as greater than 30 days (n = 43; upper 10%) and examined
the relationship between current estimated PBB exposure
and the prevalence of long cycles.
We retained women with self-reported thyroid conditions
(n = 39, 11.6%) in analyses to avoid adjusting for possible
PBB-related thyroid-mediated menstrual cycle effects [34-
41]. We did not include in utero diethylstilbestrol expo-
sure as a covariate or exclusion due to the high number of
women reporting unknown exposure status (n = 101,
30.0%). Five women (1.5%) reported having in utero
diethylstilbestrol exposure. We performed sensitivity
analysis removing these five women from the final mod-
els. Most women lacked historical pesticide information
(n = 298; 88.4 percent); therefore, it was not included in
this analysis.
We performed Pearson partial correlation analyses
between cycle length and the logarithm of bleed length,
assessing overall associations and correlations stratified
by history of weight loss. We also performed correlation
analyses between the logarithm of both PBB and PCB, and
age in years. All analyses were performed using SAS Ver-
sion 9.1 (SAS Institute Inc., Cary, NC).
Table 1: Characteristics of 337 women,* Michigan Female Health Study, 1997–1998.
Population Characteristics Distribution
Continuous Variables Point Estimate (Range)
Median PBB level (ppb) measured at cohort enrollment 2.0 (0.5–1490)
Median PBB level (ppb) estimated at study interview 0.1 (0–1005)
Median initial PCB level (ppb) measured in cohort follow-up 5.0 (1.5–78) †
Mean age (years) at study interview 37.8 (24–56)
Mean BMI (kg/m2) at study interview 26.6 (16.9–53.1)
Categorical Variables N (%)
Past Year History of Weight Loss = 10% No 293(86.9%)
Yes 44 (13.0%)
Amount of weekly exercise Low (Never) 48 (14.2%)
Moderate (1 or 2 times) 137 (40.6%)
High (3 or more times) 152 (45.1%)
Lifetime smoking status Never Smoker 222 (65.9%)
Ever Smoker 115 (34.1%)
Educational attainment High School Grad or Less 132 (39.2%)
Some College or Technical 110 (32.6%)
College or Postgrad 95 (28.2%)
Annual Household Income Less Than $35,000 113 (33.5%)
At Least $35,000 207 (61.4%)
Unknown 17 (5.0%)
* Cycle lengths ranging from 20–35 days. † 44 missing PCB levels.Page 5 of 14
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Descriptive statistics of the study population
After restricting our sample to women with cycle lengths
between 20–35 days, average cycle and bleed lengths were
27.7 days and 5.3 days, respectively. The women, all
white, ranged in age from 24 to 56 years. Most never
smoked and reported some form of weekly exercise. Edu-
cational attainment was evenly distributed across PBB ter-
tiles. Forty-four women (13.0%) reported losing 10% or
more of their body weight in the past year (Table 1).
In our sample, 318 women (94.4%) had enrolled in the
cohort by the end of 1977. The remaining 19 (5.6%)
enrolled over the next 9 years. Using the exponential
decay model [30], we extrapolated enrollment levels of
PBB over an average of 20.5 years (median: 20.6; 25th %:
20.3; 75th %: 20.9; range: 10.3–22.4; in years) to estimate
PBB levels at the time of the MFHS interview. Most
women categorized as having low, middle, or high PBB
exposure at enrollment were classified the same way by
estimated current PBB tertiles (75.7%, 57.5%, and 79.2%,
respectively in Table 2). If laboratory LODs were applied
to the decay estimates, 277 women (82.2%) would cur-
rently have PBB levels below 1 ppb (median: 0.13; mean:
7.73; 25th %: 0.03; 75th %: 0.51; range: 0–1005; in ppb). A
total of 86 women were common to our study (25.5% of
337) and the decay study (22.6% of 380).
We observed digit preferences in reporting menstrual
cycle length for 30 days and 7-day multiples, noting peaks
at 21 (n = 18), 28 (n = 112), and 30 (n = 64) days (Figure
2). The distribution of bleed length did not exhibit digit
preferences. Because we allowed women to report their
usual bleed length either directly or in a range, 84 women
(24.9%) had half-day estimates (Figure 3).
Crude associations between PBB, PCB, and population 
characteristics
Average cycle length did not differ among women when
stratified by PBB exposure at enrollment or by PBB expo-
sure estimated at the time of the interview. There was a
suggested increase in bleed length with increasing PBB ter-
tiles at enrollment and time of interview (Table 3).
Age and BMI were positively correlated (r = 0.13, p =
0.02). The data suggested that women in the lowest tertile
Table 2: Cross tabulation of PBB tertiles from two timeframes, Michigan Female Health Study, 1997–1998.
No. in Tertiles of PBB 
Exposure Measured at 
Cohort Enrollment, 
(Range, ppb)
No. in Tertiles of PBB Exposure Estimated at Time of Study Interview (Range, ppb) Total No.
Low (0.00–0.06) Middle (>0.06–0.32) High (>0.32)
Low (≤ 1.0) 84 27 0 111
Middle (1.0–3.0) 23 69 28 120
High (>3.0) 5 17 84 106
Total No. 112 113 112 337
Table 3: Menstrual cycle outcomes by PBB tertiles from two time frames, Michigan Female Health Study, 1997–1998.
Outcomes Tertiles of PBB Estimated at Study Interview 
(No.)
P * (df) Tertiles of PBB Measured at Cohort 
Enrollment (No.)
P * (df)








5.0 (1.3) 5.1 (1.3) 5.2 (1.3) 0.36 (2) 4.9 (1.3) 5.1 (1.3) 5.3 (1.3) 0.14 (2)
* ANOVA F test for continuous variables. † Exponentiated from log(bleed length).Page 6 of 14
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versely, women in the highest tertile of estimated current
PBBs were older and had higher BMIs (Table 4). Previ-
ously, Blanck et al also noted slower PBB decay among
women with higher BMIs [30]. We found little difference
in the frequency of weight loss in the past year and in the
usual levels of weekly physical activity by PBB tertiles
(Table 4).
The frequency of diagnosed thyroid conditions did not
differ across either PBB tertiles estimated at interview or
measured at enrollment (p = 0.76 and 0.46, respectively;
2 df). Mean menstrual cycle length and bleed length did
not differ when stratified by history of thyroid disorders
(p = 0.09 and 0.58, respectively; 1 df). Enrollment PBBs
and enrollment PCBs were positively correlated among
the 293 women with both measures available (r = 0.12, p
= 0.04); however, estimated current PBBs and enrollment
PCBs, were not (r = 0.06, p = 0.27). Age was positively cor-
related with PCBs (r = 0.18, p = 0.002), but not PBBs
(enrollment: r = -0.09, p = 0.10; adjusted current: r = 0.02,
p = 0.66).
Multiple regression models for cycle length and bleed 
length
No grossly influential observations were noted in model
diagnostics. The adjusted R2 values for linear regression
models were 5% for cycle length and 7% for the logarithm
of bleed length.
We observed an association between physical activity and
bleed length, but not cycle length, regardless of PBB cate-
gories used in the models. Women with high levels of
physical activity had bleed lengths 0.92 times shorter than
those with moderate levels (95% confidence limits: 0.87,
0.97).
We found no overall association between current esti-
mated PBBs and either menstrual cycle length or bleed
length; however, the associations between PBB exposure
and menstrual cycle length or bleed length differed for
women based on their history of weight loss in the past
year. The interaction terms for past year weight loss and
PBB tertiles were not statistically significant for cycle
length (Table 5). When we considered women with
weight loss in the highest decile of estimated current PBB
exposure, the interaction term was significant. This small
group of women (n = 4) had cycle lengths 3.55 days
shorter (95% confidence limits: -6.45, -0.65) than the ref-
erent group. We observed a similar association using
upper decile enrollment PBB levels with even fewer
women with weight loss (n = 3). Their mean cycle lengths
were 5.54 days shorter (95% confidence limits: -8.83, -
2.26) than their respective referent group. These three
were among the four women with weight loss in the upper
decile of estimated current PBBs.
Women with weight loss also exhibited a monotonic
increase in bleed length with increasing PBB exposure rel-
ative to referent women in the low PBB tertile without
weight loss. Among women with weight loss in estimated
current PBB tertiles, those in the low tertile had shorter
bleed lengths than the referent group with a ratio of 0.82;
those in the middle tertile had a bleed length ratio of 0.92;
and those in the high tertile had longer bleed lengths with
a ratio of 1.27 (test for interaction: p < 0.0001) (Table 6).
Table 4: Menstrual cycle covariates by PBB tertiles from two time frames, Michigan Female Health Study, 1997–1998.
Covariates Tertiles of PBB Estimated at Study Interview 
(No.)
P * (df) Tertiles of PBB Measured at Cohort 
Enrollment (No.)
P * (df)
Low (112) Middle (113) High (112) Low (111) Middle (120) High (106)
Continuous Variables
Mean Age (SD), years 37.7 (6.9) 36.8 (6.1) 38.8 (6.9) 0.07 (2) 38.9 (6.4) 37.1 (6.4) 37.3 (7.2) 0.07 (2)
Mean BMI (SD), kg/m2 25.8 (5.4) 26.9 (6.5) 27.0 (6.8) 0.28 (2) 27.5 (6.4) 26.3 (6.4) 25.8 (5.9) 0.12 (2)
Amount of Weekly Exercise
Low No. (%) 14 (12.5) 17 (15.0) 17 (15.2) 0.27 (4) 13 (11.7) 15 (12.5) 20 (18.9) 0.27 (4)
Moderate No. (%) 38 (33.9) 48 (42.5) 51 (45.5) 41 (36.9) 50 (41.7) 46 (43.4)
High No. (%) 60 (53.6) 48 (42.5) 44 (39.3) 57 (51.4) 55 (45.8) 40 (37.7)
Past Year History of Weight Loss = 10%
Without No. (%) 95 (84.8) 97 (85.8) 101 (90.2) 0.45 (2) 97 (87.4) 103 (85.8) 93 (87.7) 0.90 (2)
With No. (%) 17 (15.2) 16 (14.2) 11 (9.8) 14 (12.6) 17 (14.2) 13 (12.3)
* ANOVA F test for continuous variables; Chi square test for categorical variables.Page 7 of 14
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the upper decile (test for interaction: p = 0.002, data not
shown). We also noted PBB-weight loss interactions with
enrollment PBB tertiles that were consistent with the
models for estimated current PBB tertiles and bleed length
(test for interaction: p = 0.08) (Table 6).
We also examined the cumulative distribution functions
(CDF) for log-transformed current estimated PBBs. There
was no difference in the distribution of PBBs between
women who did and did not report past year weight loss
(exact two-sided Wilcoxon p = 0.61). We further exam-
ined the CDFs for PBB distributions among the 44 women
with past year weight loss by menstrual cycle length and
bleed length categories (Figure 4). We dichotomized PBB
Table 5: Cycle length by weight loss and PBB tertiles, Michigan Female Health Study, 1997–1998. Adjusted for PCB, BMI and age at 
interview, physical activity, smoking history, education, income.
Difference in Cycle Length, (days)
Without Weight Loss With Weight Loss
No. Diff (95% CI) No. Diff (95% CI)
Tertiles of PBB Estimated at Study Interview §
Low 95 0.00 Ref 17 -0.28 (-1.79 to 1.22)
Middle 97 0.35 (-0.48 to 1.18) 16 0.21 (-1.34 to 1.76)
High 101 0.30 (-0.53 to 1.13) 11 -1.04 (-2.86 to 0.77)
Test for Interaction: p = 0.57, 2 df




Low 97 0.00 Ref 14 0.35 (-1.27 to 1.98)
Middle 103 0.01 (-0.80 to 0.82) 17 -1.02 (-2.53 to 0.48)
High 93 0.54 (-0.30 to 1.39) 13 -0.22 (-1.88 to 1.46)
Test for Interaction: p = 0.45, 2 df
* Cycle lengths ranging from 20–35 days.
Table 6: Bleed length by weight loss and PBB tertiles, Michigan Female Health Study, 1997–1998. Adjusted for PCB, BMI and age at 
interview, physical activity, smoking history, education, income.
Ratio of Bleed Length *
Without Weight Loss With Weight Loss
No. Ratio (95% CI) No. Ratio (95% CI)
Tertiles of PBB Estimated at Study Interview §
Low 95 1.00 Ref 17 0.82 (0.72 to 0.93)
Middle 97 0.92 (0.85 to 1.01) 16 0.92 (0.80 to 1.06)
High 101 1.00 (0.91 to 1.09) 11 1.27 (1.08 to 1.50)
Test for Interaction: p < 0.0001, 2 df
Tertiles of PBB Measured at Cohort Enrollment
Low 97 1.00 Ref 14 0.89 (0.78 to 1.03)
Middle 103 1.03 (0.96 to 1.10) 17 0.98 (0.86 to 1.12)
High 93 1.03 (0.96 to 1.11) 13 1.16 (1.00 to 1.34)
Test for Interaction: p = 0.08, 2 df
* Exponentiated from difference in log(bleed length).Page 8 of 14
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days) and also for longer bleed length in the upper quar-
tile (≥ 6 days). CDFs for PBBs did not differ for women
with shorter cycle lengths (Wilcoxon p = 0.63); however,
the CDFs for PBBs stratified for longer bleed length were
different (Wilcoxon p = 0.006). We observed that women
who had longer bleed lengths with past year weight loss
were more likely to have higher PBB levels (Figure 4).
Aging one year shortened cycle length by 0.10 day (95 per-
cent confidence interval: -0.14 to -0.05) regardless of the
PBB categories included in multiple regression models.
Bleed length had a J-shaped relationship with age that was
modified by estimated current PBB categories (tertile and
decile models, tests for interaction: p = 0.04). Due to the
curvilinear effect with age modeled as a continuous varia-
ble, a clear dose-response in these models was difficult to
discern. Therefore, we repeated tests for these interactions
with age quintiles cross-classified with estimated current
PBB categories (tertile model: p = 0.03; decile model: p =
0.01). The women who were 24–31 years old in the upper
tertile of estimated PBB exposure (n = 17) had bleed
lengths 0.79 times shorter than the 36 to 38 year olds in
the lowest tertile (n = 20) (95 percent confidence interval:
0.67, 0.93). The 24–31 year olds in the upper decile of
exposure (n = 8) had bleed lengths 0.70 times shorter (95
percent confidence interval: 0.57, 0.87). We did not
observe the same effect for bleed length with enrollment
level PBBs. The MFHS women in the youngest age quintile
(n = 59) were 6–13 years old at the time of the Michigan
incident.
In our sensitivity analysis of women who were the same
age as those in the exponential decay model, we excluded
140 women less than 16 years at enrollment (41.5%). We
found that, despite this restriction to 197 women, all sig-
nificant PBB-weight loss interactions persisted for both
cycle length (adjusted PBB for upper decile, p = 0.04; ini-
tial PBB for upper decile, p= 0.02) and bleed length
(adjusted PBB tertiles and upper decile, p < 0.0001; initial
PBB tertile, p = 0.01; initial PBB for upper decile, 0.04).
For the PBB-age interaction for bleed length with esti-
mated current PBBs, we no longer noted a significant age
interaction (tertile model: p = 0.38; decile model: p =
0.32). This is reasonable due to the age restriction
imposed on this even smaller sample of women. In addi-
tion, among the 197 women, age was no longer an inde-
pendent predictor of cycle length.
We tested the interaction between PBBs and PCBs for the
full sample of 337 women including 44 women missing
PCBs, and for the subset of 293 women with both PBB
and PCB measures available. No significant interactions
were detected for either enrollment or estimated current
PBBs with enrollment PCBs, for either cycle length or
bleed length. In our secondary analysis of long cycle
length, we found no overall association between PBB
exposure and menstrual cycle length greater than 30 days
(n = 43; upper 10%).
In addition, the sensitivity analyses removing the five
women with in utero DES exposure did not affect our
results.
Discussion
Normal menstrual cyclicity is a marker of successful follic-
ular recruitment and ovulation. Factors such as aging,
weight loss, body composition, and physical activity are
thought to affect menstrual cycle function through the
hypothalamic-pituitary-adrenal axis [42-52]. Physical
Cumulative distribution functions for estimated current log(PBB) among women with weight lo sFi ure 4
Cumulative distribution functions for estimated cur-
rent log(PBB) among women with weight loss. 
Shorter cycle length defined as lower 25th%. Longer bleed 
length defined as upper 75th%. T1 = Low Tertile; T2 = Middle 
Tertile; T3 = High Tertile.Page 9 of 14
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tion in this sample of women. We observed bleed length
shortening with increased physical activity that was con-
sistent with the literature [45,46]. We did not observe
menstrual cycle lengthening with physical activity as was
reported in another sample of Michigan women [47]. Our
observation of cycle length shortening with increasing age
is supported by the literature as well. Older women who
are still menstruating exhibit accelerated development of
dominant follicles and shorter mean cycle lengths due to
shorter follicular phases [53], and follicle density has been
clinically measured and mathematically modeled to
decrease with age [54-56].
Weight loss, lactation, and pregnancy mobilize lipophilic
chemicals like PBBs, normally resistant to elimination,
from adipose tissue into systemic circulation, and poten-
tially induce menstrual cycle and other endocrine changes
[57-61]. We found no overall association between PBB
exposure and menstrual cycle length or bleed length, but
significant interactions between PBB exposure and past
year weight loss not related to pregnancy were found for
both cycle length and bleed length. Our results were con-
sistent for both estimated current and measured enroll-
ment PBB concentrations. Among women with weight
loss, those in the highest tertile of PBB exposure experi-
enced longer bleed length than women in the lowest ter-
tile. Among the women in the lowest PBB tertile with
weight loss, we observed shorter bleed length, as might be
expected among women with weight loss in the general
population [48-51]. We did not observe any differences in
cycle length with PBB exposure or weight loss when PBB
was categorized in tertiles. However, among the small
number of women in the upper decile of PBB exposure
who experienced weight loss, cycle length was shorter by
3.5 days. The direction of this effect is consistent with
observations of women exposed to PCBs through fish
consumption [9], but not with the longer cycles observed
by Cooper et al in their multicenter cohort [10]. On the
other hand, we observed no association between PCB
exposure and menstrual cycle length or bleed length. Mul-
tiple testing and small numbers were a major concern. It
is possible that our results were due to chance or artifac-
tual findings. We did, however, observe the same cycle
length and bleed length differences among women with
weight loss when we restricted our analysis to an even
smaller subsample of 197 women at least 16 years old at
cohort enrollment.
We also observed significant age-related interactions with
PBB exposure for bleed length. We found no evidence in
the literature that bleed length is a correlate of age among
regularly cycling women in the general population. We
observed age-related bleed length differences only in asso-
ciation with current estimated PBB exposure, not with
measured enrollment PBB levels. The observed age inter-
action with PBB exposure could have been spuriously
introduced by the exponential decay model we used to
estimate current PBB exposure or from small numbers.
Nevertheless, we found that women who were 6–13 years
old at the time of the Michigan incident (now 24–31
years) in the highest tertile and decile of current estimated
PBBs had shorter bleed length relative to 36–38 year old
women in the low tertile (n = 20). We restricted women in
this study to those who were not transplacentally exposed
to PBBs. Therefore, our sample was restricted to women
who were exposed to PBBs only by the oral route. The age
interaction we observed may indicate that women who
were orally exposed before they reached menarche may
have been affected during developmental maturation
toward menses. Eskenazi et al reported longer cycle length
in relation to higher levels of postnatal premenarcheal
dioxin exposure, but no differences in bleed length [62].
Blanck et al found earlier age at menarche among a differ-
ent sample of Michigan girls exposed both in utero to high
maternal PBB levels and through breastfeeding [31].
These studies suggest that reproductive events may be
affected by the timing and route of developmental and
pre-pubertal exposure to halogenated hydrocarbons.
Laboratory assays of urine hormone levels have been use-
ful to document concomitant ovulatory status with self-
reported cycle length and bleed length [11,22]. Our reli-
ance on self-reported menstrual cycle information alone is
a limitation reported by others [10,63] and may be a
source of misclassification. The resulting bias from selec-
tive over-reporting of certain days would most likely
weight the resulting differences in cycle length toward the
median (or toward the null hypothesis) (Figure 2). We did
not observe digit preferences in the distribution of bleed
length (Figure 3). Bleed length, normally shorter in dura-
tion compared to cycle length, may be less prone to recall
bias. A larger sample and prospectively collected men-
strual data would improve the reliability of these self-
reported outcome measures.
We were also limited by our reliance on decay estimates of
current PBB exposure. Uncertainties in the original decay
model were previously described: lack of information on
weight gain or loss during cohort follow-up; lack of fast-
ing requirements for blood draws; lack of serum lipid
standardization of the PBB measures; detection methods
evolving over time; and most women having only two
PBB measurements [30]. Strengths of the decay model
over previous PBB half-life studies included: inclusion of
PBB determinations over longer follow-up; inclusion of
women at much lower initial PBB levels; inclusion of a
much larger sample of women; and in addition to age and
BMI, the inclusion of information on breastfeeding dura-
tion, smoking, and parity [30].Page 10 of 14
(page number not for citation purposes)
Environmental Health: A Global Access Science Source 2005, 4:15 http://www.ehjournal.net/content/4/1/15Eligibility requirements for our study differed from the
decay model study. The decay analysis restricted inclusion
to females who were at least 16 years of age. Our lower age
bound only required women to have been born before the
contamination episode. Our sensitivity analysis excluding
females below 16 years found similar results to our full
model. We also included women with enrollment PBB
levels below 2 ppb (n = 112), essentially those women in
our low enrollment tertile below the LOD (Table 2). It is
possible that different kinetics apply at levels below the
lower enrollment PBB inclusion bound of the decay
model. The decay model found that half-life was shorter
among women with low compared to high enrollment
PBB levels [30]. Assuming the decay model holds for lev-
els below 2 ppb, and assuming BMI constant, the current
PBB estimates would not be biased. If the decay model
fails below 2 ppb, third-order kinetics may apply. If the
true half-life is shorter for enrollment PBBs below 2 ppb
than above, then the decay model would overestimate
current PBB levels, given a woman's BMI. In this case,
women with low PBB levels at interview would be mis-
classified in higher adjusted PBB tertiles, and differences
in cycle length or bleed length may be underestimated. If
the true half-life is longer for enrollment PBBs below 2
ppb, then we would observe an overestimation of effect.
We extrapolated our results further out to the time of the
MFHS interview (22.4 years maximum) than the original
decay model (11.1 years maximum). We acknowledge
that this longer extrapolation is a limitation; however,
data on long-term decay are not available. We believe that
by using this decay model to estimate current PBB expo-
sure that either no bias or an underestimation of effect is
more likely, given the complex and nonlinear relationship
between initial PBB level, BMI, and half-life described by
Blanck et al [30].
Laboratory detection methods for PBBs changed over time
to include PCB and pesticide determinations, and are
described elsewhere [30,64], while early MDCH biologic
sampling protocols did not require fasting blood draws
nor standardization for serum lipids [2,60,64-68]. Non-
fasting samples have higher mean concentrations of
lipophilic compounds and higher total serum lipids than
fasting samples. Postprandial increases in serum lipids
have been shown to fluctuate with serum chlorinated
hydrocarbon levels over a 24-hour period [69]. The lack of
fasting requirements may add some measurement error in
this present study; however; we believe that it would result
in nondifferential misclassification. A woman's exposure
status, even if known, is unlikely to prompt her decision
to eat in relation to the time of a blood draw. Therefore,
bias would most likely be toward the null hypothesis.
More recently, Schisterman et al proposed that lipid
standardization is highly prone to bias, and advocate
careful definitions of a causal framework for exposure, lip-
ids, and health outcomes. There are study design frame-
works when models not standardized for total lipids,
equivalent to wet weight analyses, would be preferred
[70]. Estrogens and other exogenous hormones are
believed to alter plasma lipid and lipoprotein levels [71],
and we hypothesize that potential endocrine disruptors,
like PBBs or PCBs, may do the same. Since adiposity,
energy homeostasis, and ovulation are believed to be
intrinsically related [72], adjusting PBB or PCB levels for
serum lipids could inappropriately adjust for the expo-
sures themselves [70]. If this framework for the interrela-
tionships holds true, then our lack of lipid
standardization may not necessarily be a limitation. Sta-
tistical differences have been previously noted comparing
lipid adjusted and wet weight analyses. When Cooper et al
adjusted their menstrual cycle analyses for lipids, their
serum-lipid analyses between PCBs with cycle length were
somewhat attenuated compared to wet-weight analyses,
but not with bleed length [10].
Our PBB exposure levels quantify only of the main conge-
ner, PBB 153. Different PBB congeners may have different
endocrine-related effects related to menstrual function as
suggested in some studies of PCBs [10,11] and by other
proposed disruptors [62,73-78]. In congener-specific
analyses, Cooper et al observed shorter cycle length with
increasing exposure to PCB 52. This is in contrast to cycle
lengthening when total PCBs are considered [10]. Wind-
ham et al noted that cycle length may decrease with
increasing levels of PCB 187 but not with other congeners
[11]. Rat and hamster models for follicular atresia and
ovulatory delay with phenobarbital administration have
been demonstrated [75-78], and PBB 153 is a phenobar-
bital-type inducer [27]. Among smokers, folliculotoxic
effects of polycyclic aromatic hydrocarbons on primordial
oocytes have been implicated in earlier menopause [79-
82], while no relation between PBB exposure and time to
menopause was found among women in the MFHS [83].
Other chemicals believed to alter endocrine function
include dichlorodiphenyltrichloroethane (DDT), 1,1-
dichloro-2,2-bis(p-chlorophenyl)ethylene (DDE), and
polybrominated diphenyl ethers (PBDEs) [10,11,84,85].
The MFHS is limited by the lack of extensive information
on these additional exposures.
Conclusion
This study suggests that PBB exposure may impact ovarian
function as indicated by menstrual cycle length and bleed
length. However, these associations were found among
the small number of women with recent weight loss sug-
gesting either a chance finding or that mobilization of
PBBs from lipid stores may be important. These results
should be replicated with larger numbers of women
exposed to lipophilic compounds.Page 11 of 14
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